Targetable signaling pathway mutations are associated with malignant phenotype in IDH- mutant gliomas von Wakimoto, H, Tanaka, S, Curry, W.T, Loebel, F, Zhao, D, Tateishi, K, Chen, J, Klofas, L.K, Lelic, N, Kim, J.C, Dias-Santagata, D, Ellisen, L.W, Borger, D.R, Fendt, Sarah-Maria, Vander Heiden, M.G, Batchelor, T.T, Iafrate, A.J, Cahill, D.P, Chi, A.S

Volltext